Kamada Past Earnings Performance
Past criteria checks 2/6
Kamada's earnings have been declining at an average annual rate of -48.8%, while the Biotechs industry saw earnings growing at 12.3% annually. Revenues have been growing at an average rate of 1.2% per year. Kamada's return on equity is 3.4%, and it has net margins of 5.8%.
Key information
-48.8%
Earnings growth rate
-49.0%
EPS growth rate
| Biotechs Industry Growth | 17.0% |
| Revenue growth rate | 1.2% |
| Return on equity | 3.4% |
| Net Margin | 5.8% |
| Next Earnings Update | 08 May 2024 |
Revenue & Expenses BreakdownBeta
How Kamada makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 143 | 8 | 32 | 12 |
| 30 Sep 23 | 152 | 6 | 32 | 12 |
| 30 Jun 23 | 146 | 3 | 32 | 12 |
| 31 Mar 23 | 135 | 0 | 31 | 10 |
| 31 Dec 22 | 129 | -2 | 29 | 12 |
| 30 Sep 22 | 115 | -10 | 27 | 11 |
| 30 Jun 22 | 106 | -12 | 24 | 11 |
| 31 Mar 22 | 107 | -7 | 22 | 11 |
| 31 Dec 21 | 104 | -2 | 20 | 9 |
| 30 Sep 21 | 104 | 4 | 19 | 9 |
| 30 Jun 21 | 116 | 12 | 19 | 10 |
| 31 Mar 21 | 125 | 15 | 17 | 11 |
| 31 Dec 20 | 133 | 17 | 17 | 12 |
| 30 Sep 20 | 134 | 21 | 16 | 12 |
| 30 Jun 20 | 132 | 20 | 16 | 12 |
| 31 Mar 20 | 134 | 23 | 16 | 11 |
| 31 Dec 19 | 127 | 22 | 16 | 11 |
| 30 Sep 19 | 143 | 35 | 16 | 10 |
| 30 Jun 19 | 125 | 26 | 15 | 9 |
| 31 Mar 19 | 124 | 26 | 14 | 8 |
| 31 Dec 18 | 114 | 22 | 14 | 8 |
| 30 Sep 18 | 102 | 11 | 14 | 7 |
| 30 Jun 18 | 110 | 13 | 15 | 8 |
| 31 Mar 18 | 109 | 12 | 15 | 9 |
| 31 Dec 17 | 103 | 7 | 15 | 10 |
| 30 Sep 17 | 91 | -1 | 15 | 11 |
| 30 Jun 17 | 88 | -2 | 15 | 12 |
| 31 Mar 17 | 74 | -8 | 14 | 12 |
| 31 Dec 16 | 77 | -7 | 14 | 13 |
| 30 Sep 16 | 79 | -4 | 16 | 12 |
| 30 Jun 16 | 76 | -8 | 15 | 13 |
| 31 Mar 16 | 76 | -8 | 15 | 12 |
| 31 Dec 15 | 70 | -11 | 15 | 12 |
| 30 Sep 15 | 69 | -11 | 14 | 11 |
| 30 Jun 15 | 70 | -9 | 14 | 11 |
| 31 Mar 15 | 67 | -15 | 14 | 12 |
| 31 Dec 14 | 71 | -13 | 15 | 12 |
| 30 Sep 14 | 71 | -13 | 10 | 16 |
| 30 Jun 14 | 71 | -10 | 9 | 15 |
| 31 Mar 14 | 71 | -1 | 9 | 12 |
| 31 Dec 13 | 71 | 0 | 10 | 11 |
| 30 Sep 13 | 68 | 2 | 10 | 11 |
| 30 Jun 13 | 68 | 2 | 9 | 11 |
Quality Earnings: KMDA has high quality earnings.
Growing Profit Margin: KMDA became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: KMDA's earnings have declined by 48.8% per year over the past 5 years.
Accelerating Growth: KMDA has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: KMDA has become profitable in the last year, making it difficult to compare its past year earnings growth to the Biotechs industry (-14%).
Return on Equity
High ROE: KMDA's Return on Equity (3.4%) is considered low.